Clinical trial
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus…
NCT00457392 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00457392 |
|---|---|
| Title | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone |
| Official title | A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy And Safety Study Of Sunitinib (SU011248) In Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Treated With Erlotinib |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small Cell Lung |
| Intervention type | Drug |
| Interventions | erlotinib, sunitinib, placebo |
| Enrollment | 960 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2012 |
| First posted | Apr 6, 2007 |
| Last update posted | Oct 29, 2013 |
| Countries | Argentina, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Germany, Greece, Hong Kong and 14 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: